2022
DOI: 10.3390/cancers14081982
|View full text |Cite
|
Sign up to set email alerts
|

A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care

Abstract: A major gap impeding development of new treatments for cancer-related fatigue is an inadequate understanding of the complex biological, clinical, demographic, and lifestyle mechanisms underlying fatigue. In this paper, we describe a new application of a comprehensive model for cancer-related fatigue: the predisposing, precipitating, and perpetuating (3P) factors model. This model framework outlined herein, which incorporates the emerging field of metabolomics, may help to frame a more in-depth analysis of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 167 publications
1
16
0
Order By: Relevance
“…Drugs such as methylphenidate [43, 44] and interventions such as cognitive behavioural therapy [45, 46] have been shown to improve fatigue in cancer patients and survivors and help them achieve the best possible quality of life after CRC diagnosis. Early implementation of evidence‐based fatigue management strategies and care options will benefit patients during and after cancer therapy [47–50]. Our findings, along with the existing evidence [8, 37, 51], are in accordance with guidelines from the National Comprehensive Cancer Network that call for initiating early screening for fatigue and continual monitoring of fatigue until treatment completion.…”
Section: Discussionsupporting
confidence: 82%
“…Drugs such as methylphenidate [43, 44] and interventions such as cognitive behavioural therapy [45, 46] have been shown to improve fatigue in cancer patients and survivors and help them achieve the best possible quality of life after CRC diagnosis. Early implementation of evidence‐based fatigue management strategies and care options will benefit patients during and after cancer therapy [47–50]. Our findings, along with the existing evidence [8, 37, 51], are in accordance with guidelines from the National Comprehensive Cancer Network that call for initiating early screening for fatigue and continual monitoring of fatigue until treatment completion.…”
Section: Discussionsupporting
confidence: 82%
“…In this model, we follow a recently proposed principle of segregating factors associated with complex symptoms into that which pre-disposes one to experience fatigue, factors that are essential for experience of fatigue (precipitating factors), and those that perpetuate fatigue. 84 While outside the scope of this paper, there are several known pre-disposing factors associated with PSF 19,85 which are included in the model, and discussed in the SRRR paper. The essential conditions for development of PSF start with high levels of inflammation setting into motion changes in innate immune response and changes in metabolic pathways.…”
Section: A Unifying Model Of Fatiguementioning
confidence: 99%
“…The review should compare fatigue definitions, assessment methods, key mechanisms, common themes on treatment, and future directions. The 3 P's model, factors that predispose, precipitate, and perpetuate fatigue, was agreed to provide a useful overarching framework (Sleight et al, 2022). Second, results of the scoping review could be used to construct a core outcome set of items to be used in fatigue phenotyping.…”
Section: Topic 4: Phenotypingmentioning
confidence: 99%